100.26
price down icon0.04%   -0.04
after-market Handel nachbörslich: 100.50 0.24 +0.24%
loading
Schlusskurs vom Vortag:
$100.30
Offen:
$99.99
24-Stunden-Volumen:
16.63M
Relative Volume:
1.24
Marktkapitalisierung:
$248.85B
Einnahmen:
$63.90B
Nettoeinkommen (Verlust:
$19.05B
KGV:
13.26
EPS:
7.5596
Netto-Cashflow:
$13.05B
1W Leistung:
+1.34%
1M Leistung:
+7.90%
6M Leistung:
+22.70%
1J Leistung:
-1.71%
1-Tages-Spanne:
Value
$98.00
$100.94
1-Wochen-Bereich:
Value
$96.06
$100.94
52-Wochen-Spanne:
Value
$73.31
$105.84

Merck Co Inc Stock (MRK) Company Profile

Name
Firmenname
Merck Co Inc
Name
Telefon
908-740-4000
Name
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Name
Mitarbeiter
75,000
Name
Twitter
@Merck
Name
Nächster Verdiensttermin
2025-02-04
Name
Neueste SEC-Einreichungen
Name
MRK's Discussions on Twitter

Vergleichen Sie MRK mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
MRK
Merck Co Inc
100.26 248.95B 63.90B 19.05B 13.05B 7.5596
Drug Manufacturers - General icon
LLY
Lilly Eli Co
1,062.19 919.64B 59.42B 18.41B 6.44B 20.22
Drug Manufacturers - General icon
JNJ
Johnson Johnson
214.17 509.76B 92.15B 25.12B 20.46B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
227.45 394.69B 59.64B 2.36B 19.68B 1.3253
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
135.19 254.37B 54.45B 14.42B 17.15B 7.333

Merck Co Inc Stock (MRK) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-11-24 Hochstufung Wells Fargo Equal Weight → Overweight
2025-11-13 Eingeleitet Scotiabank Sector Outperform
2025-10-13 Fortgesetzt Citigroup Neutral
2025-09-17 Herabstufung Berenberg Buy → Hold
2025-05-14 Herabstufung Citigroup Buy → Neutral
2025-04-22 Eingeleitet Cantor Fitzgerald Neutral
2025-02-18 Herabstufung Deutsche Bank Buy → Hold
2025-02-10 Herabstufung TD Cowen Buy → Hold
2025-01-08 Herabstufung Truist Buy → Hold
2024-12-20 Herabstufung BMO Capital Markets Outperform → Market Perform
2024-12-10 Fortgesetzt BofA Securities Buy
2024-12-04 Hochstufung HSBC Securities Hold → Buy
2024-11-15 Eingeleitet Wolfe Research Peer Perform
2024-11-11 Herabstufung Daiwa Securities Buy → Neutral
2024-10-17 Eingeleitet Bernstein Mkt Perform
2024-03-11 Herabstufung Societe Generale Hold → Sell
2024-01-04 Hochstufung TD Cowen Market Perform → Outperform
2023-11-09 Eingeleitet Deutsche Bank Buy
2023-10-27 Hochstufung BMO Capital Markets Market Perform → Outperform
2023-10-20 Hochstufung UBS Neutral → Buy
2023-07-14 Eingeleitet HSBC Securities Hold
2023-04-13 Hochstufung Citigroup Neutral → Buy
2023-03-28 Herabstufung Societe Generale Buy → Hold
2023-03-13 Herabstufung Wells Fargo Overweight → Equal Weight
2023-03-06 Eingeleitet Jefferies Buy
2023-02-22 Hochstufung Wolfe Research Peer Perform → Outperform
2023-01-04 Hochstufung BofA Securities Neutral → Buy
2022-11-18 Eingeleitet Credit Suisse Outperform
2022-10-10 Hochstufung Guggenheim Neutral → Buy
2022-09-14 Hochstufung Berenberg Hold → Buy
2022-07-06 Hochstufung Daiwa Securities Neutral → Buy
2022-06-06 Fortgesetzt SVB Leerink Outperform
2022-04-06 Fortgesetzt Morgan Stanley Equal-Weight
2021-12-17 Eingeleitet Goldman Buy
2021-12-16 Eingeleitet Daiwa Securities Neutral
2021-12-13 Herabstufung UBS Buy → Neutral
2021-12-09 Eingeleitet Wells Fargo Overweight
2021-12-07 Herabstufung Guggenheim Buy → Neutral
2021-11-29 Herabstufung Citigroup Buy → Neutral
2021-11-19 Eingeleitet BMO Capital Markets Market Perform
2021-11-01 Hochstufung Argus Hold → Buy
2021-09-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-07-27 Fortgesetzt Truist Buy
2021-05-20 Herabstufung Argus Buy → Hold
2021-04-07 Fortgesetzt RBC Capital Mkts Sector Perform
2020-11-10 Fortgesetzt Bernstein Outperform
2020-09-29 Eingeleitet Berenberg Hold
2020-08-03 Hochstufung Goldman Neutral → Buy
2020-06-12 Herabstufung Wolfe Research Outperform → Peer Perform
2020-02-27 Eingeleitet Barclays Overweight
2020-01-07 Eingeleitet RBC Capital Mkts Sector Perform
2019-10-17 Fortgesetzt BofA/Merrill Neutral
2019-08-16 Eingeleitet SVB Leerink Outperform
2019-07-03 Eingeleitet Mizuho Buy
2019-05-28 Eingeleitet Goldman Neutral
2019-05-13 Hochstufung Atlantic Equities Neutral → Overweight
2018-10-16 Bestätigt Citigroup Buy
2018-10-09 Fortgesetzt Guggenheim Buy
2018-04-23 Hochstufung Goldman Neutral → Buy
2018-04-17 Hochstufung Morgan Stanley Equal-Weight → Overweight
2018-04-05 Hochstufung Barclays Equal Weight → Overweight
2018-03-12 Hochstufung Leerink Partners Mkt Perform → Outperform
2018-02-14 Bestätigt Leerink Partners Mkt Perform
2018-02-07 Bestätigt Morgan Stanley Equal-Weight
2018-01-16 Hochstufung SunTrust Hold → Buy
Alle ansehen

Merck Co Inc Aktie (MRK) Neueste Nachrichten

pulisher
Dec 15, 2025

Merck Stock (MRK) News Today: BofA Raises Target to $120 as Winrevair Expansion and Dividend Date Spotlight 2026 Outlook - ts2.tech

Dec 15, 2025
pulisher
Dec 15, 2025

Gilead's Experimental Combo Tablet For HIV Treatment Hits Primary Goal - Benzinga

Dec 15, 2025
pulisher
Dec 15, 2025

Merck & Co's Options: A Look at What the Big Money is Thinking - Benzinga

Dec 15, 2025
pulisher
Dec 15, 2025

Valeo Financial Advisors LLC Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

V. M. Manning & CO. Inc. Invests $1.17 Million in Merck & Co., Inc. $MRK - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Bank of America Analyst Says - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Neville Rodie & Shaw Inc. Trims Stake in Merck & Co., Inc. $MRK - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Merck & Co., Inc. $MRK Shares Sold by Texas Permanent School Fund Corp - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Stance Capital LLC Invests $1.26 Million in Merck & Co., Inc. $MRK - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Merck & Co., Inc. $MRK Shares Sold by Kestra Investment Management LLC - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Rep. Julie Johnson Sells Off Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Cullen Capital Management LLC Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Merck & Co., Inc. $MRK Shares Bought by Corient Private Wealth LLC - MarketBeat

Dec 15, 2025
pulisher
Dec 14, 2025

Merck & Co., Inc.: - marketscreener.com

Dec 14, 2025
pulisher
Dec 14, 2025

Merck stock (MRK): News, dividend date, Keytruda updates and analyst forecasts to watch before the U.S. market opens Dec. 15, 2025 - ts2.tech

Dec 14, 2025
pulisher
Dec 14, 2025

MASTERINVEST Kapitalanlage GmbH Invests $2.92 Million in Merck & Co., Inc. $MRK - MarketBeat

Dec 14, 2025
pulisher
Dec 14, 2025

Sterile Bioprocess Filtration Market to Hit USD 21.20 Billion by 2032, Driven by Rising Biologics Production and Adoption of Single Use Filtration Technologies - GlobeNewswire Inc.

Dec 14, 2025
pulisher
Dec 14, 2025

Immuno-oncology Clinical Trials Market Projected to Reach USD 23.63 Billion by 2032 at a CAGR of 12.37% - GlobeNewswire Inc.

Dec 14, 2025
pulisher
Dec 14, 2025

Thrivent Financial for Lutherans Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 14, 2025
pulisher
Dec 14, 2025

Kentucky Retirement Systems Lowers Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 14, 2025
pulisher
Dec 14, 2025

Thompson Davis & CO. Inc. Invests $1.17 Million in Merck & Co., Inc. $MRK - MarketBeat

Dec 14, 2025
pulisher
Dec 14, 2025

North Dallas Bank & Trust Co. Invests $919,000 in Merck & Co., Inc. $MRK - MarketBeat

Dec 14, 2025
pulisher
Dec 14, 2025

National Bank of Canada FI Boosts Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 14, 2025
pulisher
Dec 14, 2025

Public Sector Pension Investment Board Reduces Stake in Merck & Co., Inc. $MRK - MarketBeat

Dec 14, 2025
pulisher
Dec 14, 2025

Merck & Co., Inc. $MRK Shares Bought by Evergreen Capital Management LLC - MarketBeat

Dec 14, 2025
pulisher
Dec 14, 2025

B. Riley Wealth Advisors Inc. Takes Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 14, 2025
pulisher
Dec 13, 2025

LM Advisors LLC Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

Merck & Co., Inc. $MRK Shares Purchased by Lazard Asset Management LLC - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

Bcwm LLC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

Curi Capital LLC Buys 65,987 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

Bridgeway Capital Management LLC Grows Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

Brevan Howard Capital Management LP Buys Shares of 448,919 Merck & Co., Inc. $MRK - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

Merck & Co., Inc. $MRK Stock Holdings Lifted by BI Asset Management Fondsmaeglerselskab A S - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

Benjamin Edwards Inc. Increases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

Guggenheim lifts PT on Merck & Co. (MRK) to $122 from $104 - MSN

Dec 13, 2025
pulisher
Dec 13, 2025

Bellevue Group AG Sells 203,132 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

Banque Transatlantique SA Sells 418,552 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

AQR Capital Management LLC Buys 1,029,454 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 13, 2025
pulisher
Dec 12, 2025

Merck & Co Inc (MRK) Price Today - CoinMarketCap

Dec 12, 2025
pulisher
Dec 12, 2025

Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.3% After Analyst Upgrade - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

Merck (MRK) Stock News Today: Winrevair EU Expansion, Keytruda Patent Headwinds, Analyst Forecasts and What Investors Watch (Dec. 12, 2025) - ts2.tech

Dec 12, 2025
pulisher
Dec 12, 2025

Merck & Co (MRK) Analyst Ratings Update: Morgan Stanley Raises P - GuruFocus

Dec 12, 2025
pulisher
Dec 12, 2025

Merck & Co., Inc. (NYSE:MRK) Given New $102.00 Price Target at Morgan Stanley - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

Morgan Stanley Adjusts Merck & Co. PT to $102 From $100, Maintains Equalweight Rating - marketscreener.com

Dec 12, 2025
pulisher
Dec 12, 2025

Merck Receives Positive EU CHMP Opinion For Expanded Use Of WINREVAIR In Adults With Pulmonary Arterial Hypertension - TradingView — Track All Markets

Dec 12, 2025
pulisher
Dec 12, 2025

Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension) - Business Wire

Dec 12, 2025
pulisher
Dec 12, 2025

Peapack Gladstone Financial Corp Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

Ieq Capital LLC Acquires 348,203 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

HUB Investment Partners LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

Merck & Co., Inc. $MRK Shares Sold by Sei Investments Co. - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

CIBC Asset Management Inc Sells 78,956 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 12, 2025

Finanzdaten der Merck Co Inc-Aktie (MRK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general NVS
$135.19
price up icon 1.98%
drug_manufacturers_general NVO
$50.37
price up icon 0.38%
$325.31
price up icon 2.38%
drug_manufacturers_general PFE
$26.43
price up icon 2.24%
$119.78
price down icon 0.51%
Kapitalisierung:     |  Volumen (24h):